food and drug administration

Food and Drug Administration, cancer and Recall

FDA: Over Half a Million Bottles of Blood Pressure Drug Recalled Over Cancer Risk Concerns

The U.S. Food and Drug Administration (FDA) announced that more than 580,000 bottles of the blood pressure medication prazosin hydrochloride have been recalled due to concerns that some batches may co...

· 1d

Blood pressure drug recalled over cancer concerns. What it means for Ohioans

· 18h · on MSN

FDA says drug makers have recalled a blood pressure medicine tainted with a cancer-causing chemical

· 9h

FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical

The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-cau...

· 20h

FDA: Once Again A Blood Pressure Medication Recall For Cancer Concerns

· 12h

Blood pressure medication recalled over potential carcinogen: What to know

· 9h

Teva Pharmaceuticals recalls blood pressure medication. How to check your medication

The recall involves more than 580,000 prazosin hydrochloride capsules distributed by Teva Pharmaceuticals.

· 21h

Blood pressure medication recalled over level of cancerous chemical

· 1d

Recall alert: 580K bottles of blood pressure medications recalled due to cancer-causing chemical

India Today on MSN

First GLP-1 drug approved to protect against heart attacks, stroke

The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, to reduce cardiovascular risk in type 2 diabetes patients. The drug can be prescribed to reduce major adverse cardiovascular issues even in patients who have not yet experienced these events.

Watch live: RFK Jr., FDA chief give remarks on lowering drug prices

Health and Human Services Secretary Robert F. Kennedy Jr. and Food and Drug Administration (FDA) Commissioner Marty Makary will give remarks on the Trump administration’s push to lower drug

11hon MSN

FDA announces plans to relax rules about copycat drugs

The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some high-priced medications to reduce costs.

20h

FDA’s New Fast Drug Review Plan Comes With Trade-Offs for Pharma

The FDA’s effort to expedite reviews for drugs in line with the Trump administration’s priorities was greeted warmly by a pharmaceutical industry interested in moving approvals more quickly, but raised concerns about the scope of the plan in light of recent cuts at the agency.

13hon MSN